Y020-8659 Screening compound: 4-{2-[6-(3-bromophenyl)-4,6-dihydro-1H-[1,3,5]triazino[1',2':3,4][1,3,5]triazino[1,2-a][1,3]benzimidazol-2(3H)-yl]ethyl}morpholine

Y020-8659 Screening compound: 4-{2-[6-(3-bromophenyl)-4,6-dihydro-1H-[1,3,5]triazino[1',2':3,4][1,3,5]triazino[1,2-a][1,3]benzimidazol-2(3H)-yl]ethyl}morpholine
Y020-8659 Screening compound: 4-{2-[6-(3-bromophenyl)-4,6-dihydro-1H-[1,3,5]triazino[1',2':3,4][1,3,5]triazino[1,2-a][1,3]benzimidazol-2(3H)-yl]ethyl}morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-8659
4-{2-[6-(3-bromophenyl)-4,6-dihydro-1H-[1,3,5]triazino[1',2':3,4][1,3,5]triazino[1,2-a][1,3]benzimidazol-2(3H)-yl]ethyl}morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-8659

Molecular Formula

C23H26BrN7O (C23 H26 BrN7 O)

Compound Name

4-{2-[6-(3-bromophenyl)-4,6-dihydro-1H-[1,3,5]triazino[1',2':3,4][1,3,5]triazino[1,2-a][1,3]benzimidazol-2(3H)-yl]ethyl}morpholine

IUPAC name

9-(3-bromophenyl)-4-[2-(morpholin-4-yl)ethyl]-24681017-hexaazatetracyclo[8.7.0.0^{27}.0^{1116}]heptadeca-1(17)7111315-pentaene

SMILES

Brc1cc(C2N=C(NCN(CCN3CCOCC3)C3)N3c3nc(cccc4)c4n23)ccc1

InChI

InChI=1S/C23H26BrN7O/c24-18-5-3-4-17(14-18)21-27-22-25-15-29(9-8-28-10-12-32-13-11-28)16-30(22)23-26-19-6-1-2-7-20(19)31(21)23/h1-7,14,21H,8-13,15-16H2,(H,25,27)/t21-/m1/s1

InChI Key

CLONTIOIHKSBIK-OAQYLSRUSA-N

MDL Number (MFCD)

MFCD09438837

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

496.41

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.918

Distribution Coefficient, logD

3.028

Water Solubility, LogSw

-4.04

Polar Surface Area

50.532

Acid Dissociation Constant (pKa)

17.95

Base Dissociation Constant (pKb)

8.23

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

39.10

Y020-8659 in Drug Discovery

Included in Screening Libraries

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with Y020-8659 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-8659?
Check Price and Availability of Y020-8659, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-8659 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-8659
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-8659
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-8659 available by request